Fiocruz News
Displaying 1771 - 1800 of 2491
Technical Seminar on Access to COVID-19 Vaccines brought together representatives of five countries days before bloc meeting
Otávio Pieri, of the Oswaldo Cruz Institute (IOC), was invited to become part of the group
Because of the COVID-19 pandemic, the conversation between the Foundation and Palace of Ife was stalled
The request is to include Bio-manguinhos as the manufacturing unit of the Active Pharmaceutical Ingredient
Published in the 'Journal of Infectious Diseases', the study points out that process can lead to acute immunodeficiency in patients
Research highlights the second dose importance to guarantee more complete immunity and broader protection for the community
Fiocruz researcher Carlos Morel is member of Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), formed by WHO
The Foundation joined the global campaign "Don't Forget Hansen's" and held a webinar about neglected diseases with Novartis
The initiative allows students to get dual-degrees or titles in master's and doctorate's degrees
Participants mention a lot of statements and commitments, but a lack of distinction of responsibilities and obligation in fulfilling the goals set
Nísia Trindade Lima was appointed for The World Academy of Sciences for the advancement of science in developing countries (TWAS)
Two webinars - from WHO and CRIS/Fiocruz- celebrated the document’s anniversary and evaluate the actions adopted since then
The study carried out in São Paulo showed a vaccine effectivity of 93.6% against death in people above 60 years old
They signed a joint declaration for the acquisition of API with the goal of producing 60 million doses of the COVID-19 vaccine
34 laboratories of different countries participated in this phase of the research that aims to validate the immuno-enzymatic method
There is a before and after COVID-19 in the way of thinking technology, says Paulo Gadelha, EFA 2030 coordinator
All the production process of the Active Pharmaceutical Ingredient used for COVID-19 vaccines includes 81 tests in Brazil and United States
José Graziano, former director of FAO and current coordinator of the Zero Hunger Institute, took part on the webinar
António Sales and Nísia Trindade Lima discussed cooperation agreements that date back to the beginning of the 20th century
The study led by Cidacs/Fiocruz Bahia suggests that C-sections may be associated with a higher risk of infant mortality, with the exception of cases with medical indication
After a one-year break due to the restrictions caused by the COVID-19 pandemic, Fioantar resumed its scientific excursions
The conference was part of the Global Health Colloquium Series, a biannual series of lectures by university's Program in Global Health
Depois de um ano de intervalo devido às restrições provocadas pela pandemia de Covid-19, o projeto Fiocruz na Antártica (Fioantar) retomou as expedições científicas ao continente com um novo embarque na manhã desta quarta-feira (13/10)
Ambassador Tebogo Montshome wants to identify areas of possible cooperation between her country and the Foundation
The Pharmaceutical Plant in Maputo is the result of the technology transfer mission and partnership with the Institute of Technology in Medicines (Farmanguinhos/Fiocruz)
The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the virus
The document is an initiative of Planetary Health Alliance and USP, in partnership with the United Nations Development Programme
The medicine is indicated for schistosomiasis, a parasitic disease that affects about 200 million people worldwide, half of whom are children
In a review published by the HCSM/Fiocruz journal, Jonathan Ablard reports that problems related to food in Latin America are secular
The results indicate a decrease in effectiveness with advancing age, which reinforces previous researchs involving AstraZeneca and Coronavacvac